Kaunas, Lithuania, 2011-09-07 14:50 CEST (GLOBE NEWSWIRE) -- The Board of SANITAS AB, having familiarised itself with the mandatory non-competitive tender offer material presented to it by the Valeant Pharmaceuticals International, Inc., in its meeting held on 7 September 2011 made the following statement (attached).
A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of SANITAS AB phone number +370 686 67779.
Lawyer
Dovilė Morkytė
+370 615 15163
